vorinostat has been researched along with Pneumonia in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Pneumonia: Infection of the lung often accompanied by inflammation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Q | 1 |
| Su, Z | 1 |
| Song, S | 1 |
| Χu, H | 1 |
| Zhang, B | 1 |
| Yi, L | 1 |
| Tian, M | 1 |
| Wang, H | 1 |
1 other study available for vorinostat and Pneumonia
| Article | Year |
|---|---|
Histone deacetylase inhibitors suppress RSV infection and alleviate virus-induced airway inflammation.
Topics: Animals; Blotting, Western; Bronchi; Cell Line; Cell Line, Tumor; Cyclooxygenase 2; Cytokines; Epith | 2016 |